In gastric cancer cells, miR-665 is able to directly target and inhibit Cysteine Rich Transmembrane BMP Regulator 1(CRIM1) and MAPK1(ERK2) to decrease the proliferation of cancer cells [27,28]. The gene discussed is MAPK1; the disease is gastric cancer.